A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

BACKGROUND: The calcineurin inhibitor (CNI)-based immune maintenance regimen that is commonly used after renal transplantation has greatly improved early graft survival after transplantation; however, the long-term prognosis of grafts has not been significantly improved. The nephrotoxicity of CNI dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiang, Zhang, Weijie, Zhou, Hua, Cao, Ronghua, Shou, Zhangfei, Zhang, Shuwei, Cheng, Ying, Chen, Xuchun, Ding, Chenguang, Tang, Zuofu, Li, Ning, Shi, Shaohua, Zhou, Qiang, Chen, Qiuyuan, Chen, Gang, Chen, Zheng, Zhou, Peijun, Hu, Xiaopeng, Zhang, Xiaodong, Na, Ning, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532037/
https://www.ncbi.nlm.nih.gov/pubmed/35861301
http://dx.doi.org/10.1097/CM9.0000000000001866

Ejemplares similares

Ejemplares similares